Primary |
Drug Use For Unknown Indication |
31.7% |
Product Used For Unknown Indication |
22.1% |
Bipolar Disorder |
9.7% |
Convulsion |
7.7% |
Maternal Exposure Timing Unspecified |
5.0% |
Epilepsy |
3.9% |
Drug Exposure During Pregnancy |
3.4% |
Depression |
2.9% |
Bipolar I Disorder |
1.8% |
Hypertension |
1.6% |
Affective Disorder |
1.5% |
Anxiety |
1.4% |
Maternal Exposure During Pregnancy |
1.2% |
Migraine |
1.1% |
Mania |
1.1% |
Schizophrenia |
0.9% |
Schizoaffective Disorder |
0.9% |
Diabetes Mellitus |
0.8% |
Psychotic Disorder |
0.7% |
Insomnia |
0.7% |
|
Tension |
14.2% |
Weight Increased |
11.0% |
Tremor |
8.7% |
Alopecia |
7.2% |
Convulsion |
7.1% |
Vomiting |
5.7% |
Unevaluable Event |
5.5% |
Thrombocytopenia |
4.5% |
Medication Residue |
4.3% |
Somnolence |
4.1% |
Ammonia Increased |
3.2% |
Rash |
3.1% |
Drug Level Decreased |
3.0% |
Drug Ineffective |
2.9% |
Ill-defined Disorder |
2.9% |
Weight Decreased |
2.8% |
Pancreatitis |
2.5% |
Platelet Count Decreased |
2.5% |
Product Substitution Issue |
2.4% |
Pain |
2.3% |
|
Secondary |
Product Used For Unknown Indication |
21.3% |
Bipolar Disorder |
14.0% |
Drug Use For Unknown Indication |
13.8% |
Convulsion |
10.4% |
Depression |
7.0% |
Epilepsy |
4.8% |
Bipolar I Disorder |
3.5% |
Hypertension |
3.1% |
Anxiety |
2.7% |
Schizoaffective Disorder |
2.6% |
Affective Disorder |
2.3% |
Schizophrenia |
2.3% |
Mania |
2.2% |
Diabetes Mellitus |
2.1% |
Psychotic Disorder |
1.8% |
Migraine |
1.4% |
Pain |
1.3% |
Agitation |
1.2% |
Hypothyroidism |
1.2% |
Insomnia |
1.1% |
|
Weight Increased |
20.0% |
Tremor |
9.3% |
Vomiting |
8.6% |
Weight Decreased |
8.1% |
Thrombocytopenia |
7.2% |
Somnolence |
5.8% |
Convulsion |
4.9% |
Suicide Attempt |
4.7% |
Drug Hypersensitivity |
4.5% |
Alopecia |
3.6% |
Drug Ineffective |
3.3% |
Overdose |
2.8% |
Mania |
2.5% |
Suicidal Ideation |
2.5% |
Withdrawal Syndrome |
2.4% |
White Blood Cell Count Decreased |
2.2% |
Sedation |
2.0% |
Treatment Noncompliance |
2.0% |
Rash |
1.8% |
White Blood Cell Count Increased |
1.8% |
|
Concomitant |
Bipolar Disorder |
16.9% |
Product Used For Unknown Indication |
15.7% |
Depression |
11.9% |
Schizophrenia |
7.4% |
Drug Use For Unknown Indication |
5.9% |
Anxiety |
5.5% |
Convulsion |
4.7% |
Sleep Disorder |
3.5% |
Pain |
3.4% |
Hypertension |
3.3% |
Insomnia |
2.7% |
Epilepsy |
2.7% |
Psychotic Disorder |
2.3% |
Migraine |
2.3% |
Multiple Sclerosis |
2.1% |
Schizoaffective Disorder |
2.1% |
Affective Disorder |
2.1% |
Smoking Cessation Therapy |
1.9% |
Bipolar I Disorder |
1.9% |
Diabetes Mellitus |
1.6% |
|
Type 2 Diabetes Mellitus |
17.0% |
Weight Increased |
16.6% |
Vomiting |
8.5% |
Weight Decreased |
5.2% |
Tremor |
4.9% |
Somnolence |
4.9% |
Suicidal Ideation |
4.4% |
Convulsion |
3.9% |
Pancreatitis |
3.7% |
Drug Ineffective |
3.5% |
Death |
3.1% |
Suicide Attempt |
3.1% |
Tardive Dyskinesia |
3.1% |
Granulocytopenia |
3.1% |
Vision Blurred |
2.8% |
Nausea |
2.5% |
Urinary Tract Infection |
2.5% |
White Blood Cell Count Decreased |
2.5% |
Rash |
2.4% |
Type 1 Diabetes Mellitus |
2.2% |
|
Interacting |
Product Used For Unknown Indication |
25.0% |
Epilepsy |
14.1% |
Convulsion |
11.6% |
Drug Use For Unknown Indication |
8.6% |
Bipolar Disorder |
7.1% |
Depression |
5.3% |
Hypertension |
5.1% |
Grand Mal Convulsion |
3.5% |
Borderline Personality Disorder |
2.5% |
Migraine |
2.5% |
Fibromyalgia |
1.8% |
Pain |
1.8% |
Smoking Cessation Therapy |
1.8% |
Convulsion Prophylaxis |
1.5% |
Mental Disorder |
1.5% |
Anxiety |
1.3% |
Blood Pressure Abnormal |
1.3% |
Eye Infection |
1.3% |
Food Allergy |
1.3% |
Ingrowing Nail |
1.3% |
|
Drug Interaction |
25.3% |
Feeling Abnormal |
6.7% |
Headache |
6.7% |
Hypophagia |
5.3% |
Loss Of Consciousness |
5.3% |
Tremor |
5.3% |
Dizziness |
4.0% |
Eye Movement Disorder |
4.0% |
Hypersomnia |
4.0% |
Paranoia |
4.0% |
Platelet Count Decreased |
4.0% |
Respiratory Depression |
4.0% |
Aphasia |
2.7% |
Irritability |
2.7% |
Mood Swings |
2.7% |
Pain |
2.7% |
Psychotic Disorder |
2.7% |
Rash Erythematous |
2.7% |
Shock |
2.7% |
Speech Disorder |
2.7% |
|